仕様
| 項目 | 製品情報 |
|---|---|
| モデル | PL-400 |
| PLLA | 340 mg |
| HA | 60 mg |
| 包装形態 | 400 mg / vial |
| 粒子径 | ~30 µm |
| 針 | 27G |
| pH | 4.0–7.0 |
| 浸透圧 | 250–350 mOsm/kg |
| Normal force（資料の表記） | 0.9–2.0 N |
技術・素材
資料ではPLLAマイクロスフェア、組織反応、コラーゲン形成を配合コンセプトとして説明しています。380 mgと400 mgでは配合・調製条件が異なるため、仕様を混同しないでください。
医療従事者向け調製情報
| 項目 | 製品情報 |
|---|---|
| 0.9%生理食塩水 | 6 mL |
| リドカイン | 2 mL |
| 調製後の総量 | 8 mL |
| 水和時間 | 15–30分 |
取り扱い・アフターケア
資料には24時間以内の冷却ケアと、7-3-3マッサージ（1回3分、1日3回、7日間）が記載されています。担当医の個別の指示に従ってください。
英語原文の詳細情報
以下に製品ガイドの英語原文を保持しています。上記の翻訳概要・仕様表は資料を構造的に整理したもので、PDFはメーカーまたは提供元の原本です。
Si Belle PLLA+ 400 combines 340 mg poly-L-lactic acid (PLLA) and 60 mg hyaluronic acid (HA) in a 400 mg vial. The PL-400 model is a two-component formulation containing 85% PLLA and 15% HA, with approximately 30 µm microspheres and a stated hydration time of 15-30 minutes.
A two-component formulation
The PL-400 table lists 340 mg PLLA and 60 mg HA per vial. These quantities total 400 mg; the visible Si Belle pack lists the same component amounts.
The formula contains 85% PLLA and 15% HA by weight.
| Component | Amount per vial | Share |
|---|---|---|
| Poly-L-lactic acid (PLLA) | 340 mg | 85% |
| Hyaluronic acid (HA) | 60 mg | 15% |
| Total | 400 mg | 100% |
PLLA material and formulation principle
PLLA is poly-L-lactic acid, a polymer formed from L-lactic acid units.
The supplied catalogue presents a general PLLA rationale linking tissue response, collagen formation and material degradation.
PL-400 technical specifications
| Parameter | PL-400 value |
|---|---|
| Product model | PL-400 |
| PLLA contents | PLLA 340 mg + HA 60 mg |
| Package | 400 mg / vial |
| Particle size | Approximately 30 µm (microsphere) |
| Needle | 27G |
| Infusion volume (0.9% NaCl saline) | 6 mL |
| Hydration time | 15-30 minutes |
| pH | 4.0-7.0 |
| Osmotic pressure | 250-350 mOsm/kg |
| Normal force (N) | 0.9-2.0 N |
Professional preparation overview
The PL-400 preparation table lists 6 mL of 0.9% normal saline plus 2 mL lidocaine, for a total preparation volume of 8 mL.
| Preparation component | Volume |
|---|---|
| 0.9% normal saline | 6 mL |
| Lidocaine | 2 mL |
| Total | 8 mL |
| Step | Preparation shown in the supplied catalogue |
|---|---|
| 1. Aluminium cap | Remove the aluminium cap from the vial. |
| 2. Alcohol swab | Clean with an alcohol swab. |
| 3. Saline transfer | An 18G needle and 10 mL syringe are shown for drawing up saline. |
| 4. Powder mixing | Syringe mixing is shown; a vortex mixer is also mentioned. |
| 5. Suspension mixing | Gentle vial agitation is shown. |
| 6. Lidocaine addition | The PL-400 table specifies 2 mL. The general source illustration states 1-2 cc. |
| 7. Syringe transfer | Transfer to a 1-10 mL syringe, as shown in the source. |
| 8. Blunt cannula | The source preparation illustration lists 26-30G and deep dermal/subcutaneous layers. |
Self-care for better results
The brochure describes two post-treatment care measures: cold-pack care and the 7-3-3 massage rule.
- Cold-pack care: within 24 hours after the procedure, the source advises an ice pack to reduce swelling.
- 7-3-3 rule: massage for 3 minutes, 3 times a day, for 7 days.
Before and after examples
The catalogue includes eight photograph sets across four pages.
Two facial sets show the labels Before, After 1 day, After 1 month and After 3 month.
The remaining sets show before/after views of facial contour, the buttock region, the eye area and the nasolabial region. No treatment interval is printed for these sets.
業務に関するお問い合わせ
会社名、仕向国、希望モデル、数量をご記入ください。メールアプリが開きます。お問い合わせが自動送信・保存されることはありません。
alexmoon@ictmedicalco.com ↗